Skip to main content
Biotest AG logo

Biotest AG — Investor Relations & Filings

Ticker · BIO3 ISIN · DE0005227201 LEI · 529900JVX7RPXBLYUD89 F Manufacturing
Open in API
Filings indexed 1,148 across all filing types
Latest filing 2017-11-07 Legal Proceedings Report
Country DE Germany
Listing F BIO3

About Biotest AG

https://www.biotest.com/de/en/index.cfm

Biotest AG is a global company that develops, manufactures, and supplies plasma protein products and biotherapeutic drugs. Sourced from human blood plasma, its products are primarily used in the therapeutic areas of clinical immunology, haematology, and intensive care medicine. The portfolio includes immunoglobulins (e.g., Intratect), coagulation factors, and albumins designed to treat severe and chronic diseases such as immune deficiencies, haemophilia, and coagulation disorders. The company manages the entire value chain from clinical development to sales and is advancing a pipeline of new treatments, including next-generation immunoglobulins (BT595) and fibrinogen concentrates (BT524). Biotest also provides Human Serum Albumin for use as a multifunctional excipient in pharmaceutical and diagnostic applications.

Recent filings

Filing Released Lang Actions
Tender Offer by Tiancheng (Germany) Pharmaceutical Holdings AG / Tiancheng withdrawal of application of transaction from CFIUS and refiling
Legal Proceedings Report Classification · 99% confidence The document is an 'Ad-hoc RELEASE' dated November 7, 2017, disclosing information under Article 17 of the European Market Abuse Regulation (MAR). The content discusses a 'Tender Offer' by Tiancheng for Biotest AG and the subsequent withdrawal and refiling of an application with CFIUS due to national security concerns. This type of material, which is a significant, non-periodic corporate event announcement made outside of standard financial reporting cycles (like 10-K or IR), fits best under the general 'Regulatory Filings' category, as it is a mandatory disclosure under MAR but does not align with specific categories like M&A (TAR), Director's Dealing (DIRS), or Capital Changes (CAP). Since it is a direct regulatory disclosure of a material event, RNS (Regulatory Filings) is the most appropriate classification.
2017-11-07 English
Biotest AG: Biotest AG opens eighth plasma collection centre in Hungary
Regulatory Filings Classification · 100% confidence The document is a press release announcing a specific operational update: Biotest AG opening a new plasma collection center in Hungary. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It does not fit the definitions for AGM-R, AR, MANG, CT, CAP, DVA, DLST, DIRS, SR, XLSX, FS, CGR, IRAT, IP, LTR, TAR, MRQ, MDA, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. Since it is a general corporate news announcement disseminated via DGAP (a service often used for regulatory news but here used for a general update), and it doesn't fit any other specific category, the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for miscellaneous announcements not covered elsewhere, especially those distributed through official news channels.
2017-11-06 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Notification of Major Holdings' and references Article 26, Section 1 of the WpHG (German Securities Trading Act), which governs the disclosure of major shareholdings. It details changes in voting rights percentages for UBS Group AG concerning Biotest AG. This type of filing, concerning changes in significant share ownership thresholds, directly corresponds to the definition of Major Shareholding Notification.
2017-10-26 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections like 'Notification of Major Holdings', detailing changes in voting rights percentages (Section 6) and the nature of the change (Section 2: Acquisition/disposal of shares with voting rights). This directly corresponds to the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes or related voting rights changes. Although it mentions 'DGAP Distribution Services', the core content is the voting rights notification itself, not just an announcement of a report's publication (RPA/RNS).
2017-10-24 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' under German securities law (WpHG). It details the acquisition/disposal of shares with voting rights and instruments by UBS Group AG, crossing specific percentage thresholds (e.g., 5.25% total). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels.
2017-10-19 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections detailing the 'Notification of Major Holdings' under German securities law (WpHG). It reports on the acquisition/disposal of shares with voting rights by J O Hambro Capital Management, crossing a threshold, and provides specific percentages of voting rights. This directly corresponds to the definition of a Major Shareholding Notification.
2017-10-18 English

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.